Eric Venker

Insider

President & Immunovant CEO

Trades at: ROIV· IMVT

30D 90D 1Y

Net shares · 90d

-414.2K

0 buy · 414.2K sell

Net value · 90d

-$12.3M

$0 in · $12.3M out

Sentiment · 90d

Net selling

0% buying · 100% selling

Open-market trades · 90d

0 buy · 414.2K sell

Net buy / sell volume (all companies)

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions · open-market

Include grants & non-market

ROIV Sell·S
May 22, 26

President & Immunovant CEO · 10b5-1

$6.1M

200.0K sh · $30.27

Own -11%
ROIV Sell·S
Apr 20, 26

President & Immunovant CEO · 10b5-1

$5.9M

200.0K sh · $29.59

Own -11%
IMVT Sell·S
Apr 2, 26

Chief Executive Officer

$34.7K

1.4K sh · $24.60

Own -7%
IMVT Sell·S
Apr 2, 26

Chief Executive Officer

$308.2K

12.8K sh · $24.04

Own -38%

Date▾	Ticker	Role	Type	Shares	Own Δ	Price	Value
May 22, 2026	ROIV	President & Immunovant CEO	Sell S	200.0K	-11%	$30.27	$6.1M
Apr 20, 2026	ROIV	President & Immunovant CEO	Sell S	200.0K	-11%	$29.59	$5.9M
Apr 2, 2026	IMVT	Chief Executive Officer	Sell S	1.4K	-7%	$24.60	$34.7K
Apr 2, 2026	IMVT	Chief Executive Officer	Sell S	12.8K	-38%	$24.04	$308.2K

About Eric Venker

This profile aggregates every SEC Form 4 insider transaction reported by Eric Venker across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.